Sir Tom Hunter today confirmed West Coast Capital (“WCC”), the investment arm of the Hunter family has backed Ellipses Pharma the cancer drugs venture founded by Sir Chris Evans, the biotech entrepreneur, and backed by an eclectic group of investors including the president of the United Arab Emirates. WCC made a multi-million pound investment.
Commenting Sir Tom said;
“I’ve known Chris for over 25 years and invested with him over the years. This investment for us is very exciting – the quality of the Team, world class use of expert knowledge and the intelligent disruption of financing the drug discovery…And then of course led by the force of nature that is Professor Sir Chris Evans.”
Ellipses Pharma has invested $150 million into its clinical drugs pipeline and is planning to invest another $100 million, of which $40 million was raised recently.
The company’s investors include Mohamed bin Zayed, president of the UAE, Steve Morgan, founder of the housebuilder Redrow, the Rolling Stones’ Ronnie Wood.
The venture has three “very exciting” oncology drugs
For further information review these documents: Press Release & Additional Press Article